DLI Files for $200M IPO

DLI Holding Corp., a Uniondale, N.Y.-based maker of cosmetics and over-the-counter pharmaceuticals, has filed for a $200 million IPO. It plans to trade on the Nasdaq under ticker symbol DLIH, with JP Morgan and Bear Stearns serving as co-lead underwriters. DLI is owned by private equity firm Kelso & Company.